BIOPORTO DIAGNOSTICS A/S: Financial statements 2018
CVR: 18645882
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 25,896,480 and a net result of DKK -43,730,237 compared with DKK -35,280,800 the year before. That is a decrease of 0.3% compared with the year before. The profit margin was -168.9%. Equity in the 2018 report amounted to DKK -294,707,506. The company had 17 employees in the financial year.
- Revenue
- DKK 25,896,480
- Gross Profit
- DKK -417,176
- Profit/Loss
- DKK -43,730,237
- Equity
- DKK -294,707,506
- Total Assets
- DKK 18,671,885
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 25.9 mio. | -417 t. | -43.7 mio. | -294.7 mio. | 17 |
| 2017 | 26 mio. | -2.9 mio. | -35.3 mio. | -251 mio. | 16 |
| 2016 | 20.7 mio. | 6 mio. | -28.9 mio. | -216.1 mio. | 19 |
| 2015 | 20.4 mio. | 5.5 mio. | -17.5 mio. | -187.9 mio. | 17 |
| 2014 | 18.7 mio. | 4.6 mio. | -22.8 mio. | -170.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2017. Revenue came to DKK 25,977,183, and the net result was DKK -35,280,800.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.